HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gastric inhibitory polypeptide release into the portal vein in response to intraduodenal glucose loads in anesthetized rats.

Abstract
Gastric inhibitory polypeptide (GIP) release into the portal vein in response to duodenal instillation of glucose in doses of 0.695, 1.39, 2.78 and 5.56 mmol/kg body weight was studied in an acute condition in male Wistar rats. A rapid, dose-dependent, and significant rise in portal vein plasma GIP was found in response to increasing duodenal glucose loads, which could be described by Michaelis-Menten kinetics. It is suggested that the glucose-induced GIP release into the portal vein mainly is effected first after glucose has gained access inside the mucosal cells.
AuthorsT B Schulz, P G Burhol, R Jorde, H L Waldum
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 16 Issue 8 Pg. 1061-5 ( 1981) ISSN: 0036-5521 [Print] England
PMID7336132 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gastrointestinal Hormones
  • Gastric Inhibitory Polypeptide
  • Glucose
Topics
  • Animals
  • Dose-Response Relationship, Drug
  • Duodenum (metabolism)
  • Gastric Inhibitory Polypeptide (blood)
  • Gastrointestinal Hormones (blood)
  • Glucose (pharmacology)
  • Kinetics
  • Male
  • Portal Vein (metabolism)
  • Rats
  • Rats, Inbred Strains
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: